Clinical Performance of High Viscosity Bioactive Injectable Composite in Deep Marginal Elevation (Randomized)

Future University in Egypt

Status: Not yet enrolling

Conditions: Dental; Deep Margin Elevation; DME

Treatments: Other: G-aenial Universal Injectable Flowable Composite; Other: Beautifil F00

Study type: Interventional

Funder types: Other

Identifiers

NCT06875544

Deep margin Elevation

Details and patient eligibility

About

Using a bioactive resin composite in subgingival Class II cavities can provide enhanced caries resistance by releasing multiple ions, including fluoride. This approach offers greater resistance to caries due to the incorporation of surface pre-reacted glass filler (S-PRG) technology (Imazato, Nakatsuka et al., 2023).

This type of composite may improve the outcomes of deep subgingival margin elevation, benefiting both restorative success and periodontal health.

Enrollment: 50 estimated patients

Sex: All

Ages: 20 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Adult Patient (20-50 years old)
2. Good oral hygiene (plaque index 0 or 1)
3. Patient approval
4. Absence of parafunctional habits and/or bruxism
5. No endodontic treatment
6. No abscess
7. No partial or fixed denture

Exclusion criteria

1. Patients with known allergic or adverse reaction to the tested materials.
2. Bad oral hygiene
3. Systematic disease that may affect participation.
4. Xerostomic patients.
5. Patients with active periodontal disease.
6. Heavy smokers (those who smoke greater than or equal to 25 or more cigarettes a day)
7. Orthodontic treatment patient

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Double Blind

---

50 participants in 2 patient groups

Bioactive injectable giomer

Active Comparator group

Description:

Deep margin elevation and subsequent restoration will be done using bioactive giomer material

Treatment:

Other: Beautifil F00

Nanohybrid injectable composite

Active Comparator group

Treatment:

Other: G-aenial Universal Injectable Flowable Composite